Gold nanoparticle platforms as drug and biomacromolecule delivery systems

Journal of Controlled Release

Volumn 148, Issue 1, 2010, Pages 122-127

  Duncan, Bradley ^a   Kim, Chaekyu ^a   Rotello, Vincent M ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Drug delivery; Gold; Nanoparticles

Indexed keywords

COMPLETE CONTROL; DELIVERY SYSTEMS; FUNCTIONALIZED; GOLD NANOPARTICLE; GOLD NANOPARTICLES; NANOCARRIERS; TUNABILITIES;

DRUG DELIVERY; MONOLAYERS; NANOPARTICLES; SURFACE PROPERTIES;

GOLD;

CITRIC ACID; FLUOROURACIL; GOLD NANOPARTICLE; NANOCARRIER; PHOSPHINE; THIOL DERIVATIVE;

ARTICLE; BIOCOMPATIBILITY; CELL MEMBRANE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; DRUG TRANSPORT; ENCAPSULATION; NONHUMAN; PHOTOCHEMICAL INTERNALIZATION; PRIORITY JOURNAL;

ANIMALS; CELL MEMBRANE PERMEABILITY; CISPLATIN; DRUG DELIVERY SYSTEMS; GLUTATHIONE; GOLD; HUMANS; METAL NANOPARTICLES; PARTICLE SIZE; SURFACE PROPERTIES; ULTRAVIOLET RAYS;

EID: 78649529378     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.06.004     Document Type: Article

References (84)

1. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303(5665):1818-1822.
2. Crampton H.L., Simanek E.E. Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers. Polymer International 2007, 56(4):489-496.
3. Lee C.C., MacKay J.A., Frechet J.M.J., Szoka F.C. Designing dendrimers for biological applications. Nature Biotechnology 2005, 23(12):1517-1526.
4. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery 2005, 4(2):145-160.
5. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology 2007, 2(12):751-760.
6. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug Discovery 2008, 7(9):771-782.
7. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Advanced Drug Delivery Reviews 2004, 56(11):1649-1659.
8. Gibson J.D., Khanal B.P., Zubarev E.R. Paclitaxel-functionalized gold nanoparticles. Journal of the American Chemical Society 2007, 129(37):11653-11661.
9. Paciotti G.F., Kingston D.G.I., Tamarkin L. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Development Research 2006, 67(1):47-54.
10. Schmid G. Large clusters and colloids. Metals in the embryonic state. Chemical Reviews 1992, 92(8):1709-1727.
11. Templeton A.C., Wuelfing W.P., Murray R.W. Monolayer-protected cluster molecules. Accounts of Chemical Research 1999, 33(1):27-36.
12. 55 clusters. Small 2005, 1(8-9):841-844.
13. Bhattacharya R., Mukherjee P. Biological properties of "naked" metal nanoparticles. Advanced Drug Delivery Reviews 2008, 60(11):1289-1306.
14. Connor Ellen E., Mwamuka J., Gole A., Murphy Catherine J., Wyatt Michael D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity 13. Small 2005, 1(3):325-327.
15. Park C., Youn H., Kim H., Noh T., Kook Y.H., Oh E.T., Park H.J., Kim C. Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug. Journal of Materials Chemistry 2009, 19(16):2310-2315.
16. Han G., You C.-C., Kim B.-J., Turingan R.S., Forbes N.S., Martin C.T., Rotello V.M. Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles 13. Angewandte Chemie International Edition 2006, 45(19):3165-3169.
17. Hong R., Han G., Fernandez J.M., Kim B.-J., Forbes N.S., Rotello V.M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. Journal of the American Chemical Society 2006, 128(4):1078-1079.
18. Murphy C.J., Gole A.M., Stone J.W., Sisco P.N., Alkilany A.M., Goldsmith E.C., Baxter S.C. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Accounts of Chemical Research 2008, 41(12):1721-1730.
19. Daniel M.-C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chemical Reviews 2003, 104(1):293-346.
20. Rosi N.L., Mirkin C.A. Nanostructures in biodiagnostics. Chemical Reviews 2005, 105(4):1547-1562.
21. Boisselier E., Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chemical Society Reviews 2009, 38(6):1759-1782.
22. De M., Ghosh P.S., Rotello V.M. Applications of nanoparticles in biology. Advanced Materials 2008, 20(22):4225-4241.
23. Mathias Brust M.W., Bethell Donald, Schiffrin David J., Whyman Robin Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. Journal of the Chemical Society-Chemical Communications 1994, 801-802.
24. Turkevich J., Stevenson P.C., Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discussions of the Faraday Society 1951, 55-75.
25. Grabar K.C., Freeman R.G., Hommer M.B., Natan M.J. Preparation and characterization of Au colloid monolayers. Analytical Chemistry 1995, 67(4):735-743.
26. Teranishi T., Hasegawa S., Shimizu T., Miyake M. Heat-induced size evolution of gold nanoparticles in the solid state. Advanced Materials 2001, 13(22):1699-1701.
27. Khalil H., Mahajan D., Rafailovich M., Gelfer M., Pandya K. Synthesis of zerovalent nanophase metal particles stabilized with poly(ethylene glycol). Langmuir 2004, 20(16):6896-6903.
28. Otsuka H., Nagasaki Y., Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Advanced Drug Delivery Reviews 2003, 55(3):403-419.
29. Otsuka H., Akiyama Y., Nagasaki Y., Kataoka K. Quantitative and reversible lectin-induced association of gold nanoparticles modified with α-lactosyl-ω-mercapto-poly(ethylene glycol). Journal of the American Chemical Society 2001, 123(34):8226-8230.
30. Takae S., Akiyama Y., Otsuka H., Nakamura T., Nagasaki Y., Kataoka K. Ligand density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of RCA120 lectin with lactose installed to the distal end of tethered PEG strands on gold surface. Biomacromolecules 2005, 6(2):818-824.
31. Ishii T., Otsuka H., Kataoka K., Nagasaki Y. Preparation of functionally PEGylated gold nanoparticles with narrow distribution through autoreduction of auric cation by α-biotinyl-PEG-block-[poly(2-(N, N-dimethylamino)ethyl methacrylate)]. Langmuir 2003, 20(3):561-564.
32. Olivier J.-C., Huertas R., Lee H.J., Calon F., Pardridge W.M. Synthesis of pegylated immunonanoparticles. Pharmaceutical Research 2002, 19(8):1137-1143.
33. Shimmin R.G., Schoch A.B., Braun P.V. Polymer size and concentration effects on the size of gold nanoparticles capped by polymeric thiols. Langmuir 2004, 20(13):5613-5620.
34. Cho E.C., Xie J., Wurm P.A., Xia Y. Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Letters 2009, 9(3):1080-1084.
35. Ferrari M. Nanogeometry: beyond drug delivery. Nature Nanotechnology 2008, 3(3):131-132.
36. Zhu Z.-J., Ghosh P.S., Miranda O.R., Vachet R.W., Rotello V.M. Multiplexed screening of cellular uptake of gold nanoparticles using laser desorption/ionization mass spectrometry. Journal of the American Chemical Society 2008, 130(43):14139-14143.
37. Jiang W., KimBetty Y.S., Rutka J.T., ChanWarren C.W. Nanoparticle-mediated cellular response is size-dependent. Nature Nanotechnology 2008, 3(3):145-150.
38. Perrault S.D., Walkey C., Jennings T., Fischer H.C., Chan W.C.W. Mediating tumor targeting efficiency of nanoparticles through design. Nano Letters 2009, 9(5):1909-1915.
39. Verma A., Uzun O., Hu Y., Hu Y., Han H.-S., Watson N., Chen S., Irvine D.J., Stellacci F. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nature Materials 2008, 7(7):588-595.
40. Nativo P., Prior I.A., Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2008, 2(8):1639-1644.
41. Tkachenko A.G., Xie H., Coleman D., Glomm W., Ryan J., Anderson M.F., Franzen S., Feldheim D.L. Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. Journal of the American Chemical Society 2003, 125(16):4700-4701.
42. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. Journal of Controlled Release 2001, 73(2-3):137-172.
43. Morgan M.T., Nakanishi Y., Kroll D.J., Griset A.P., Carnahan M.A., Wathier M., Oberlies N.H., Manikumar G., Wani M.C., Grinstaff M.W. Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Research 2006, 66(24):11913-11921.
44. Kim H.-J., Matsuda H., Zhou H., Honma I. Ultrasound-triggered smart drug release from a poly(dimethylsiloxane)-mesoporous silica composite. Advanced Materials 2006, 18(23):3083-3088.
45. Park C., Lim J., Yun M., Kim C. Photoinduced release of guest molecules by supramolecular transformation of self-assembled aggregates derived from dendrons 13. Angewandte Chemie International Edition 2008, 47(16):2959-2963.
46. Park H., Yang J., Seo S., Kim K., Suh J., Kim D., Haam S., Yoo K.-H. Multifunctional nanoparticles for photothermally controlled drug delivery and magnetic resonance imaging enhancement 13. Small 2008, 4(2):192-196.
47. Giri S., Trewyn B.G., Stellmaker M.P., Lin V.S.-Y. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles 13. Angewandte Chemie International Edition 2005, 44(32):5038-5044.
48. Rooseboom M., Commandeur J.N.M., Vermeulen N.P.E. Enzyme-catalyzed activation of anticancer prodrugs. Pharmacological Reviews 2004, 56(1):53-102.
49. Kam N.W.S., Liu Z., Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. Journal of the American Chemical Society 2005, 127(36):12492-12493.
50. Mayer G., Heckel A. Biologically active molecules with a "light switch". Angewandte Chemie International Edition 2006, 45(30):4900-4921.
51. McCoy C.P., Rooney C., Edwards C.R., Jones D.S., Gorman S.P. Light-triggered molecule-scale drug dosing devices. Journal of the American Chemical Society 2007, 129(31):9572-9573.
52. Nakanishi J., Nakayama H., Shimizu T., Ishida H., Kikuchi Y., Yamaguchi K., Horiike Y. Light-regulated activation of cellular signaling by gold nanoparticles that capture and release amines. Journal of the American Chemical Society 2009, 131(11):3822-3823.
53. Agasti S.S., Chompoosor A., You C.-C., Ghosh P., Kim C.K., Rotello V.M. Photoregulated release of caged anticancer drugs from gold nanoparticles. Journal of the American Chemical Society 2009, 131(16):5728-5729.
54. Anderson M.E. Glutathione: an overview of biosynthesis and modulation. Chemico-Biological Interactions 1998, 111-112:1-14.
55. Sies H. Glutathione and its role in cellular functions. Free Radical Biology and Medicine 1999, 27(9-10):916-921.
56. Jones D.P., Carlson J.L., Samiec P.S., Sternberg P., Mody V.C., Reed R.L., Brown L.A.S. Glutathione measurement in human plasma: evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clinica Chimica Acta 1998, 275(2):175-184.
57. Jones D.P., Carlson J.L., Mody V.C., Cai J., Lynn M.J., Sternberg P. Redox state of glutathione in human plasma. Free Radical Biology and Medicine 2000, 28(4):625-635.
58. McIntosh C.M., Esposito E.A., Boal A.K., Simard J.M., Martin C.T., Rotello V.M. Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters. Journal of the American Chemical Society 2001, 123(31):7626-7629.
59. Verma A., Simard J.M., Worrall J.W.E., Rotello V.M. Tunable reactivation of nanoparticle-inhibited b-galactosidase by glutathione at intracellular concentrations. Journal of the American Chemical Society 2004, 126(43):13987-13991.
60. Ghosh P., Han G., De M., Kim C.K., Rotello V.M. Gold nanoparticles in delivery applications. Advanced Drug Delivery Reviews 2008, 60(11):1307-1315.
61. Dulkeith E., Morteani A.C., Niedereichholz T., Klar T.A., Feldmann J., Levi S.A., van Veggel F.C.J.M., Reinhoudt D.N., Möller M., Gittins D.I. Fluorescence quenching of dye molecules near gold nanoparticles: radiative and nonradiative effects. Physical Review Letters 2002, 89(20):203002.
62. Sapsford K.E., Berti L., Medintz I.L. Materials for fluorescence resonance energy transfer analysis: beyond traditional donor-acceptor combinations. Angewandte Chemie International Edition 2006, 45(28):4562-4589.
63. Ghosh P.S., Kim C.-K., Han G., Forbes N.S., Rotello V.M. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano 2008, 2(11):2213-2218.
64. Agasti S.S., You C.-C., Arumugam P., Rotello V.M. Structural control of the monolayer stability of water-soluble gold nanoparticles. Journal of Materials Chemistry 2008, 18(1):70-73.
65. Chompoosor A., Han G., Rotello V.M. Charge dependence of ligand release and monolayer stability of gold nanoparticles by biogenic thiols. Bioconjugate Chemistry 2008, 19(7):1342-1345.
66. Podsiadlo P., Sinani V.A., Bahng J.H., Kam N.W.S., Lee J., Kotov N.A. Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent. Langmuir 2007, 24(2):568-574.
67. Dreaden E.C., Mwakwari S.C., Sodji Q.H., Oyelere A.K., El-Sayed M.A. Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. Bioconjugate Chemistry 2009, 20(12):2247-2253.
68. B. Asadishad, M. Vossoughi, I. Alemzadeh, Folate-Receptor-Targeted Delivery of Doxorubicin Using Polyethylene Glycol-Functionalized Gold Nanoparticles. Industrial & Engineering Chemistry Research 49(4) (2010) 1958-1963.
69. C.R. Patra, R. Bhattacharya, P. Mukherjee, Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. Journal of Materials Chemistry 20(3) (2010) 547-554.
70. Dhar S., Daniel W.L., Giljohann D.A., Mirkin C.A., Lippard S.J. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. Journal of the American Chemical Society 2009, 131(41):14652-14653.
71. S.D. Brown, P. Nativo, J.-A. Smith, D. Stirling, P.R. Edwards, B. Venugopal, D.J. Flint, J.A. Plumb, D. Graham, N.J. Wheate, Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin. Journal of the American Chemical Society 132(13) (2010) 4678-4684.
72. Love J.C., Estroff L.A., Kriebel J.K., Nuzzo R.G., Whitesides G.M. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chemical Reviews 2005, 105(4):1103-1170.
73. Hostetler M.J., Stokes J.J., Murray R.W. Infrared spectroscopy of three-dimensional self-assembled monolayers: N-alkanethiolate monolayers on gold cluster compounds. Langmuir 1996, 12(15):3604-3612.
74. Lucarini M., Franchi P., Pedulli G.F., Pengo P., Scrimin P., Pasquato L. EPR study of dialkyl nitroxides as probes to investigate the exchange of solutes between the ligand shell of monolayers of protected gold nanoparticles and aqueous solutions. Journal of the American Chemical Society 2004, 126(30):9326-9329.
75. Lucarini M., Franchi P., Pedulli G.F., Gentilini C., Polizzi S., Pengo P., Scrimin P., Pasquato L. Effect of core size on the partition of organic solutes in the monolayer of water-soluble nanoparticles: an ESR investigation. Journal of the American Chemical Society 2005, 127(47):16384-16385.
76. Kim C.K., Ghosh P., Pagliuca C., Zhu Z.-J., Menichetti S., Rotello V.M. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. Journal of the American Chemical Society 2009, 131(4):1360-1361.
77. Jin Q., Xu J.-P., Ji J., Shen J.-C. Zwitterionic phosphorylcholine as a better ligand for stabilizing large biocompatible gold nanoparticles. Chemical Communications 2008, 26:3058-3060.
78. Rouhana L.L., Jaber J.A., Schlenoff J.B. Aggregation-resistant water-soluble gold nanoparticles. Langmuir 2007, 23(26):12799-12801.
79. D'Emanuele A., Attwood D. Dendrimer-drug interactions. Advanced Drug Delivery Reviews 2005, 57(15):2147-2162.
80. Cheng Y., Samia A.C., Meyers J.D., Panagopoulos I., Fei B., Burda C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. Journal of the American Chemical Society 2008, 130(32):10643-10647.
81. Polizzi M.A., Stasko N.A., Schoenfisch M.H. Water-soluble nitric oxide-releasing gold nanoparticles. Langmuir 2007, 23(9):4938-4943.
82. Yang Q., Wang S., Fan P., Wang L., Di Y., Lin K., Xiao F.-S. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chemistry of Materials 2005, 17(24):5999-6003.
83. Mocellin S., Bronte V., Nitti D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Medicinal Research Reviews 2007, 27(3):317-352.
84. Hwu J.R., Lin Y.S., Josephrajan T., Hsu M.-H., Cheng F.-Y., Yeh C.-S., Su W.-C., Shieh D.-B. Targeted paclitaxel by conjugation to iron oxide and gold nanoparticles. Journal of the American Chemical Society 2008, 131(1):66-68.